{
  "doc_id": "5",
  "paragraphs": [
    {
      "paragraph_id": "0",
      "paragraph": "针对中国肥胖与糖尿病外科手术规范的立场声明",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "针对中国肥胖与糖尿病外科手术规范的立场声明",
          "start_idx": 0,
          "end_idx": 21,
          "entities": [
            {
              "entity_id": "T0",
              "entity": "肥胖",
              "entity_type": "Disease",
              "start_idx": 4,
              "end_idx": 6,
              "entity_en": "obesity"
            },
            {
              "entity_id": "T1",
              "entity": "糖尿病",
              "entity_type": "Disease",
              "start_idx": 7,
              "end_idx": 10,
              "entity_en": "diabetes"
            }
          ],
          "relations": [],
          "sentence_en": "Position statement on surgical procedures for obesity and diabetes in China"
        }
      ],
      "paragraph_en": "Position statement on surgical procedures for obesity and diabetes in China"
    },
    {
      "paragraph_id": "1",
      "paragraph": "我国肥胖与糖尿病外科(减重代谢外科)事业起源于2000年郑成竹教授开展的第一例腹腔镜垂直胃绑带术，经过近20年的发展，国内开展手术的医院已经超过200家，手术例数近年也呈现快速增长，这是令人可喜也值得欣慰的事。为了指导及规范该学科的健康发展，经过一定的临床实践，中华医学会外科学分会内分泌外科学组联合腹腔镜与内镜外科学组、胃肠外科学组及外科手术学学组分别于2007年和2010年先后制订和颁布了《中国肥胖病外科治疗指南(2007)》及《中国糖尿病外科治疗专家指导意见(2010)》。2012年中国医师协会外科医师分会肥胖和糖尿病外科医师委员会(Chinese Society for Metabolic and Bariatric Surgery，CSMBS)组建成立，2014年11月CSMBS发表了《中国肥胖和2型糖尿病外科治疗指南(2014)》，2014年12月人民卫生出版社出版了《肥胖与代谢病外科学》，旨在规范该学科的发展及应用。但是在学科蓬勃发展的同时，少部分医生缺乏学科专业培训，特别是在少部分基层医院，存在一些不规范的问题，如：不注意手术适用证范围，超手术指征盲目追求手术量的增加；夸大手术治疗效果，不应用创伤小并发症少的腹腔镜手术而仍然采用传统的开腹手术方法；手术方式不规范如将胃旁路的胃囊体积加大，将一些探索性的实验性手术作为治疗性手术；围手术期管理及术后随访不规范不重视，甚至缺失等情况，导致术后效果不佳或者出现一些营养问题。本声明旨在从开展手术医院及术者资质、手术指征、手术方式及术后随访管理等方面对减重代谢手术的应用做出规范。",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "我国肥胖与糖尿病外科(减重代谢外科)事业起源于2000年郑成竹教授开展的第一例腹腔镜垂直胃绑带术，经过近20年的发展，国内开展手术的医院已经超过200家，手术例数近年也呈现快速增长，这是令人可喜也值得欣慰的事。为了指导及规范该学科的健康发展，经过一定的临床实践，中华医学会外科学分会内分泌外科学组联合腹腔镜与内镜外科学组、胃肠外科学组及外科手术学学组分别于2007年和2010年先后制订和颁布了《中国肥胖病外科治疗指南(2007)》及《中国糖尿病外科治疗专家指导意见(2010)》。2012年中国医师协会外科医师分会肥胖和糖尿病外科医师委员会(Chinese Society for Metabolic and Bariatric Surgery，CSMBS)组建成立，2014年11月CSMBS发表了《中国肥胖和2型糖尿病外科治疗指南(2014)》，2014年12月人民卫生出版社出版了《肥胖与代谢病外科学》，旨在规范该学科的发展及应用。",
          "start_idx": 0,
          "end_idx": 420,
          "entities": [
            {
              "entity_id": "T2",
              "entity": "肥胖",
              "entity_type": "Disease",
              "start_idx": 2,
              "end_idx": 4,
              "entity_en": "obesity"
            },
            {
              "entity_id": "T3",
              "entity": "糖尿病",
              "entity_type": "Disease",
              "start_idx": 5,
              "end_idx": 8,
              "entity_en": "diabetes"
            },
            {
              "entity_id": "T4",
              "entity": "腹腔镜垂直胃绑带术",
              "entity_type": "Operation",
              "start_idx": 39,
              "end_idx": 48,
              "entity_en": "Laparoscopic vertical gastric banding"
            },
            {
              "entity_id": "T5",
              "entity": "糖尿病",
              "entity_type": "Disease",
              "start_idx": 220,
              "end_idx": 223,
              "entity_en": "diabetes"
            },
            {
              "entity_id": "T6",
              "entity": "肥胖病",
              "entity_type": "Disease",
              "start_idx": 200,
              "end_idx": 203,
              "entity_en": "Obesity"
            },
            {
              "entity_id": "T7",
              "entity": "肥胖",
              "entity_type": "Disease",
              "start_idx": 258,
              "end_idx": 260,
              "entity_en": "obesity"
            },
            {
              "entity_id": "T8",
              "entity": "糖尿病",
              "entity_type": "Disease",
              "start_idx": 261,
              "end_idx": 264,
              "entity_en": "diabetes"
            },
            {
              "entity_id": "T9",
              "entity": "肥胖",
              "entity_type": "Disease",
              "start_idx": 354,
              "end_idx": 356,
              "entity_en": "obesity"
            },
            {
              "entity_id": "T10",
              "entity": "2型糖尿病",
              "entity_type": "Disease",
              "start_idx": 357,
              "end_idx": 362,
              "entity_en": "Type 2 diabetes"
            },
            {
              "entity_id": "T11",
              "entity": "2型",
              "entity_type": "Class",
              "start_idx": 357,
              "end_idx": 359,
              "entity_en": "Type 2"
            },
            {
              "entity_id": "T12",
              "entity": "肥胖",
              "entity_type": "Disease",
              "start_idx": 395,
              "end_idx": 397,
              "entity_en": "obesity"
            },
            {
              "entity_id": "T13",
              "entity": "代谢病",
              "entity_type": "Disease",
              "start_idx": 398,
              "end_idx": 401,
              "entity_en": "Metabolic diseases"
            }
          ],
          "relations": [
            {
              "relation_type": "Class_Disease",
              "relation_id": "R0",
              "head_entity_id": "T11",
              "tail_entity_id": "T10"
            }
          ],
          "sentence_en": "The cause of obesity and diabetes surgery (bariatric metabolic surgery) in my country originated from the first laparoscopic vertical gastric banding performed by Professor Zheng Chengzhu in 2000. After nearly 20 years of development, there are more than 200 hospitals in China that have performed the surgery, and the number of surgeries has also shown a rapid growth in recent years, which is gratifying and gratifying. In order to guide and regulate the healthy development of this discipline, after a certain amount of clinical practice, the Endocrine Surgery Group of the Surgery Branch of the Chinese Medical Association, in conjunction with the Laparoscopy and Endoscopic Surgery Group, the Gastrointestinal Surgery Group and the Surgical Surgery Group, formulated and promulgated the \"Guidelines for the Surgical Treatment of Obesity in China (2007)\" and the \"Guidelines for the Surgical Treatment of Diabetes in China (2010)\" in 2007 and 2010 respectively. In 2012, the Chinese Society for Metabolic and Bariatric Surgery (CSMBS) was established. In November 2014, CSMBS published the \"Guidelines for the Surgical Treatment of Obesity and Type 2 Diabetes in China (2014)\". In December 2014, the People's Medical Publishing House published \"Surgery of Obesity and Metabolic Diseases\" with the aim of standardizing the development and application of this discipline."
        },
        {
          "sentence_id": "1",
          "sentence": "但是在学科蓬勃发展的同时，少部分医生缺乏学科专业培训，特别是在少部分基层医院，存在一些不规范的问题，如：不注意手术适用证范围，超手术指征盲目追求手术量的增加；夸大手术治疗效果，不应用创伤小并发症少的腹腔镜手术而仍然采用传统的开腹手术方法；手术方式不规范如将胃旁路的胃囊体积加大，将一些探索性的实验性手术作为治疗性手术；围手术期管理及术后随访不规范不重视，甚至缺失等情况，导致术后效果不佳或者出现一些营养问题。",
          "start_idx": 420,
          "end_idx": 624,
          "entities": [
            {
              "entity_id": "T14",
              "entity": "腹腔镜手术",
              "entity_type": "Operation",
              "start_idx": 99,
              "end_idx": 104,
              "entity_en": "Laparoscopic surgery"
            },
            {
              "entity_id": "T15",
              "entity": "开腹手术",
              "entity_type": "Operation",
              "start_idx": 112,
              "end_idx": 116,
              "entity_en": "Laparotomy"
            }
          ],
          "relations": [],
          "sentence_en": "However, while the discipline is booming, a small number of doctors lack professional training in the discipline, especially in a small number of grassroots hospitals, and there are some non-standard problems, such as: not paying attention to the scope of surgical indications, blindly pursuing an increase in the number of surgeries beyond surgical indications; exaggerating the effects of surgical treatment, not using laparoscopic surgery with less trauma and fewer complications but still using traditional open surgery; non-standard surgical methods such as increasing the volume of the gastric pouch for gastric bypass, and using some exploratory experimental surgeries as therapeutic surgeries; perioperative management and postoperative follow-up are not standardized, not taken seriously, or even missing, resulting in poor postoperative results or some nutritional problems."
        },
        {
          "sentence_id": "2",
          "sentence": "本声明旨在从开展手术医院及术者资质、手术指征、手术方式及术后随访管理等方面对减重代谢手术的应用做出规范。",
          "start_idx": 624,
          "end_idx": 676,
          "entities": [
            {
              "entity_id": "T16",
              "entity": "减重代谢手术",
              "entity_type": "Operation",
              "start_idx": 38,
              "end_idx": 44,
              "entity_en": "Bariatric metabolic surgery"
            }
          ],
          "relations": [],
          "sentence_en": "This statement aims to standardize the application of bariatric metabolic surgery in terms of the qualifications of surgical hospitals and surgeons, surgical indications, surgical methods and postoperative follow-up management."
        }
      ],
      "paragraph_en": "The cause of obesity and diabetes surgery (bariatric metabolic surgery) in my country originated from the first laparoscopic vertical gastric banding performed by Professor Zheng Chengzhu in 2000. After nearly 20 years of development, there are more than 200 hospitals in China that have performed the surgery, and the number of surgeries has also shown a rapid growth in recent years, which is gratifying and gratifying. In order to guide and regulate the healthy development of this discipline, after a certain amount of clinical practice, the Endocrine Surgery Group of the Surgery Branch of the Chinese Medical Association, in conjunction with the Laparoscopy and Endoscopic Surgery Group, the Gastrointestinal Surgery Group and the Surgical Surgery Group, formulated and promulgated the \"Guidelines for the Surgical Treatment of Obesity in China (2007)\" and the \"Guidelines for the Surgical Treatment of Diabetes in China (2010)\" in 2007 and 2010 respectively. In 2012, the Chinese Society for Metabolic and Bariatric Surgery (CSMBS) was established. In November 2014, CSMBS published the Chinese Guidelines for the Surgical Treatment of Obesity and Type 2 Diabetes (2014). In December 2014, the People's Medical Publishing House published the Obesity and Metabolic Disease Surgery, aiming to standardize the development and application of this discipline. However, while the discipline is booming, a small number of doctors lack professional training in the discipline, especially in a small number of grassroots hospitals, where there are some non-standard problems, such as: not paying attention to the scope of surgical indications, blindly pursuing an increase in the number of surgeries beyond surgical indications; exaggerating the effects of surgical treatment, not using laparoscopic surgery with less trauma and fewer complications, but still using traditional open surgery; non-standard surgical methods, such as increasing the size of the gastric pouch of gastric bypass, and using some exploratory experimental surgeries as therapeutic surgeries; irregular and neglected perioperative management and postoperative follow-up, or even missing, leading to poor postoperative results or some nutritional problems. This statement aims to standardize the application of bariatric metabolic surgery in terms of the qualifications of surgical hospitals and surgeons, surgical indications, surgical methods and postoperative follow-up management."
    },
    {
      "paragraph_id": "2",
      "paragraph": "一、医院及术者资质",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "一、医院及术者资质",
          "start_idx": 0,
          "end_idx": 9,
          "entities": [],
          "relations": [],
          "sentence_en": "1. Qualifications of the hospital and surgeon"
        }
      ],
      "paragraph_en": "1. Qualifications of the hospital and surgeon"
    },
    {
      "paragraph_id": "3",
      "paragraph": "肥胖与糖尿病外科手术的开展必须得到多学科协作的支持，可参考《上海市2型糖尿病外科手术管理规范》，即“手术应在三级综合性医疗单位开展，二级医院原则上不能开展，具备条件的二级医院可向省级医师协会申请并接受审核。术者应具备中级及中级以上技术职称，并具有普外科执业资质，须了解各种术式的治疗原理和操作准则，并须登记成为全国或者省级医师协会会员，经系统指导、培训获得资质后方可施行手术。”我们认为该要求对肥胖与糖尿病外科的安全和质量提供了保障，且切实可行，故建议当地医师协会根据此要求审核开展肥胖与糖尿病外科手术的医院及术者资质。",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "肥胖与糖尿病外科手术的开展必须得到多学科协作的支持，可参考《上海市2型糖尿病外科手术管理规范》，即“手术应在三级综合性医疗单位开展，二级医院原则上不能开展，具备条件的二级医院可向省级医师协会申请并接受审核。",
          "start_idx": 0,
          "end_idx": 103,
          "entities": [
            {
              "entity_id": "T17",
              "entity": "肥胖",
              "entity_type": "Disease",
              "start_idx": 0,
              "end_idx": 2,
              "entity_en": "obesity"
            },
            {
              "entity_id": "T18",
              "entity": "糖尿病",
              "entity_type": "Disease",
              "start_idx": 3,
              "end_idx": 6,
              "entity_en": "diabetes"
            },
            {
              "entity_id": "T19",
              "entity": "2型糖尿病",
              "entity_type": "Disease",
              "start_idx": 33,
              "end_idx": 38,
              "entity_en": "Type 2 diabetes"
            },
            {
              "entity_id": "T20",
              "entity": "2型",
              "entity_type": "Class",
              "start_idx": 33,
              "end_idx": 35,
              "entity_en": "Type 2"
            }
          ],
          "relations": [
            {
              "relation_type": "Class_Disease",
              "relation_id": "R1",
              "head_entity_id": "T20",
              "tail_entity_id": "T19"
            }
          ],
          "sentence_en": "The implementation of obesity and diabetes surgery must be supported by multidisciplinary collaboration. The \"Shanghai Type 2 Diabetes Surgery Management Standards\" can be used as a reference, that is, \"the surgery should be performed in tertiary comprehensive medical institutions, and secondary hospitals should not perform it in principle. Secondary hospitals that meet the conditions can apply to the provincial medical association and accept review."
        },
        {
          "sentence_id": "1",
          "sentence": "术者应具备中级及中级以上技术职称，并具有普外科执业资质，须了解各种术式的治疗原理和操作准则，并须登记成为全国或者省级医师协会会员，经系统指导、培训获得资质后方可施行手术。",
          "start_idx": 103,
          "end_idx": 188,
          "entities": [],
          "relations": [],
          "sentence_en": "The surgeon should possess an intermediate or above technical title and be qualified to practice general surgery. He or she must understand the treatment principles and operating guidelines of various surgical procedures and must be registered as a member of the national or provincial medical association. He or she may perform surgery only after obtaining qualifications through systematic guidance and training."
        },
        {
          "sentence_id": "2",
          "sentence": "”我们认为该要求对肥胖与糖尿病外科的安全和质量提供了保障，且切实可行，故建议当地医师协会根据此要求审核开展肥胖与糖尿病外科手术的医院及术者资质。",
          "start_idx": 188,
          "end_idx": 260,
          "entities": [
            {
              "entity_id": "T21",
              "entity": "肥胖",
              "entity_type": "Disease",
              "start_idx": 9,
              "end_idx": 11,
              "entity_en": "obesity"
            },
            {
              "entity_id": "T22",
              "entity": "糖尿病",
              "entity_type": "Disease",
              "start_idx": 12,
              "end_idx": 15,
              "entity_en": "diabetes"
            },
            {
              "entity_id": "T23",
              "entity": "肥胖",
              "entity_type": "Disease",
              "start_idx": 53,
              "end_idx": 55,
              "entity_en": "obesity"
            },
            {
              "entity_id": "T24",
              "entity": "糖尿病",
              "entity_type": "Disease",
              "start_idx": 56,
              "end_idx": 59,
              "entity_en": "diabetes"
            }
          ],
          "relations": [],
          "sentence_en": "\"We believe that this requirement provides assurance for the safety and quality of obesity and diabetes surgery and is feasible, so we recommend that local medical associations review the qualifications of hospitals and surgeons performing obesity and diabetes surgery based on this requirement."
        }
      ],
      "paragraph_en": "The implementation of obesity and diabetes surgery must be supported by multidisciplinary collaboration. The \"Shanghai Type 2 Diabetes Surgery Management Standards\" can be used as a reference, which states that \"the surgery should be performed in tertiary comprehensive medical institutions. In principle, it cannot be performed in secondary hospitals. Secondary hospitals that meet the conditions can apply to the provincial medical association and accept review. The surgeon should have intermediate or above technical titles and general surgery practice qualifications. He must understand the treatment principles and operating guidelines of various surgical procedures, and must be registered as a member of the national or provincial medical association. He can only perform surgery after obtaining qualifications through systematic guidance and training.\" We believe that this requirement provides a guarantee for the safety and quality of obesity and diabetes surgery and is feasible. Therefore, we recommend that local medical associations review the qualifications of hospitals and surgeons that perform obesity and diabetes surgery based on this requirement."
    },
    {
      "paragraph_id": "4",
      "paragraph": "二、手术指征",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "二、手术指征",
          "start_idx": 0,
          "end_idx": 6,
          "entities": [],
          "relations": [],
          "sentence_en": "2. Indications for surgery"
        }
      ],
      "paragraph_en": "2. Indications for surgery"
    },
    {
      "paragraph_id": "5",
      "paragraph": "肥胖与糖尿病外科手术开展的适应证及禁忌证均应参照《中国肥胖和2型糖尿病外科治疗指南(2014)》。针对肥胖伴有2型糖尿病的治疗，该版指南强调了胰岛功能储备，即T2DM病程小于15年，且空腹血清C肽水平高于正常值下限的二分之一。对于体质量指数(body mass index，BMI)介于25.0~27.5kg/m2的患者，即使合并T2DM及其他肥胖相关疾病，也应慎重开展手术。建议此类病人应先选择内科治疗，若内科治疗效果不佳或不能耐受，且病人强烈要求手术治疗，可在充分告知后，依据临床试验的路径行手术治疗。",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "肥胖与糖尿病外科手术开展的适应证及禁忌证均应参照《中国肥胖和2型糖尿病外科治疗指南(2014)》。针对肥胖伴有2型糖尿病的治疗，该版指南强调了胰岛功能储备，即T2DM病程小于15年，且空腹血清C肽水平高于正常值下限的二分之一。对于体质量指数(body mass index，BMI)介于25.0~27.5kg/m2的患者，即使合并T2DM及其他肥胖相关疾病，也应慎重开展手术。",
          "start_idx": 0,
          "end_idx": 188,
          "entities": [
            {
              "entity_id": "T25",
              "entity": "肥胖",
              "entity_type": "Disease",
              "start_idx": 0,
              "end_idx": 2,
              "entity_en": "obesity"
            },
            {
              "entity_id": "T26",
              "entity": "糖尿病",
              "entity_type": "Disease",
              "start_idx": 3,
              "end_idx": 6,
              "entity_en": "diabetes"
            },
            {
              "entity_id": "T27",
              "entity": "肥胖",
              "entity_type": "Disease",
              "start_idx": 27,
              "end_idx": 29,
              "entity_en": "obesity"
            },
            {
              "entity_id": "T28",
              "entity": "2型糖尿病",
              "entity_type": "Disease",
              "start_idx": 30,
              "end_idx": 35,
              "entity_en": "Type 2 diabetes"
            },
            {
              "entity_id": "T29",
              "entity": "2型",
              "entity_type": "Class",
              "start_idx": 30,
              "end_idx": 32,
              "entity_en": "Type 2"
            },
            {
              "entity_id": "T30",
              "entity": "肥胖",
              "entity_type": "Disease",
              "start_idx": 51,
              "end_idx": 53,
              "entity_en": "obesity"
            },
            {
              "entity_id": "T31",
              "entity": "2型糖尿病",
              "entity_type": "Disease",
              "start_idx": 55,
              "end_idx": 60,
              "entity_en": "Type 2 diabetes"
            },
            {
              "entity_id": "T32",
              "entity": "2型",
              "entity_type": "Class",
              "start_idx": 55,
              "end_idx": 57,
              "entity_en": "Type 2"
            },
            {
              "entity_id": "T33",
              "entity": "T2DM",
              "entity_type": "Disease",
              "start_idx": 79,
              "end_idx": 83,
              "entity_en": "T2DM"
            },
            {
              "entity_id": "T34",
              "entity": "T2",
              "entity_type": "Class",
              "start_idx": 79,
              "end_idx": 81,
              "entity_en": "T2"
            },
            {
              "entity_id": "T35",
              "entity": "空腹血清C肽水平",
              "entity_type": "Test_items",
              "start_idx": 92,
              "end_idx": 100,
              "entity_en": "Fasting serum C-peptide level"
            },
            {
              "entity_id": "T36",
              "entity": "高于正常值下限的二分之一",
              "entity_type": "Test_Value",
              "start_idx": 100,
              "end_idx": 112,
              "entity_en": "Above one-half of the lower limit of normal"
            },
            {
              "entity_id": "T37",
              "entity": "T2DM",
              "entity_type": "Disease",
              "start_idx": 165,
              "end_idx": 169,
              "entity_en": "T2DM"
            },
            {
              "entity_id": "T38",
              "entity": "T2",
              "entity_type": "Class",
              "start_idx": 165,
              "end_idx": 167,
              "entity_en": "T2"
            },
            {
              "entity_id": "T39",
              "entity": "肥胖",
              "entity_type": "Disease",
              "start_idx": 172,
              "end_idx": 174,
              "entity_en": "obesity"
            }
          ],
          "relations": [
            {
              "relation_type": "Class_Disease",
              "relation_id": "R2",
              "head_entity_id": "T29",
              "tail_entity_id": "T28"
            },
            {
              "relation_type": "Class_Disease",
              "relation_id": "R3",
              "head_entity_id": "T32",
              "tail_entity_id": "T31"
            },
            {
              "relation_type": "Class_Disease",
              "relation_id": "R4",
              "head_entity_id": "T34",
              "tail_entity_id": "T33"
            },
            {
              "relation_type": "Test_items_Disease",
              "relation_id": "R5",
              "head_entity_id": "T35",
              "tail_entity_id": "T33"
            },
            {
              "relation_type": "Class_Disease",
              "relation_id": "R6",
              "head_entity_id": "T38",
              "tail_entity_id": "T37"
            }
          ],
          "sentence_en": "The indications and contraindications for surgical treatment of obesity and diabetes should refer to the \"Guidelines for the Surgical Treatment of Obesity and Type 2 Diabetes in China (2014)\". For the treatment of obesity with type 2 diabetes, this version of the guidelines emphasizes the reserve of pancreatic islet function, that is, the duration of T2DM is less than 15 years, and the fasting serum C-peptide level is higher than half of the lower limit of normal value. For patients with a body mass index (BMI) between 25.0 and 27.5 kg/m2, even if they have T2DM and other obesity-related diseases, surgery should be performed with caution."
        },
        {
          "sentence_id": "1",
          "sentence": "建议此类病人应先选择内科治疗，若内科治疗效果不佳或不能耐受，且病人强烈要求手术治疗，可在充分告知后，依据临床试验的路径行手术治疗。",
          "start_idx": 188,
          "end_idx": 253,
          "entities": [],
          "relations": [],
          "sentence_en": "It is recommended that such patients should first choose medical treatment. If medical treatment is ineffective or cannot be tolerated, and the patient strongly requests surgical treatment, surgical treatment can be performed according to the clinical trial pathway after full disclosure."
        }
      ],
      "paragraph_en": "The indications and contraindications for surgical operations for obesity and diabetes should refer to the \"Guidelines for the Surgical Treatment of Obesity and Type 2 Diabetes in China (2014)\". For the treatment of obesity with type 2 diabetes, this version of the guidelines emphasizes the reserve of pancreatic islet function, that is, the duration of T2DM is less than 15 years, and the fasting serum C-peptide level is higher than half of the lower limit of normal value. For patients with a body mass index (BMI) between 25.0 and 27.5 kg/m2, even if they have T2DM and other obesity-related diseases, surgery should be performed with caution. It is recommended that such patients should first choose medical treatment. If the medical treatment is ineffective or cannot be tolerated, and the patient strongly requests surgical treatment, surgical treatment can be performed according to the path of clinical trials after being fully informed."
    },
    {
      "paragraph_id": "6",
      "paragraph": "《中国肥胖和2型糖尿病外科治疗指南(2014)》中将建议手术年龄定为16~65岁。然而根据循证医学证据，手术对于肥胖及相关代谢综合征的治疗效果，年龄并不是一个显著的影响因素，且对于青少年而言，生理、心理发育程度与生物学年龄不一定相符。故我们认为对于年龄的建议可根据临床评估结果适当放宽，特别是对于青少年，在经过对肥胖程度及代谢性疾病严重程度的评估、患者及家庭成员心理评估、术后管理依从性评估之后可慎重考虑手术。",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "《中国肥胖和2型糖尿病外科治疗指南(2014)》中将建议手术年龄定为16~65岁。",
          "start_idx": 0,
          "end_idx": 41,
          "entities": [
            {
              "entity_id": "T40",
              "entity": "肥胖",
              "entity_type": "Disease",
              "start_idx": 3,
              "end_idx": 5,
              "entity_en": "obesity"
            },
            {
              "entity_id": "T41",
              "entity": "2型糖尿病",
              "entity_type": "Disease",
              "start_idx": 6,
              "end_idx": 11,
              "entity_en": "Type 2 diabetes"
            },
            {
              "entity_id": "T42",
              "entity": "2型",
              "entity_type": "Class",
              "start_idx": 6,
              "end_idx": 8,
              "entity_en": "Type 2"
            }
          ],
          "relations": [
            {
              "relation_type": "Class_Disease",
              "relation_id": "R7",
              "head_entity_id": "T42",
              "tail_entity_id": "T41"
            }
          ],
          "sentence_en": "The \"Guidelines for Surgical Treatment of Obesity and Type 2 Diabetes in China (2014)\" sets the recommended age for surgery at 16 to 65 years old."
        },
        {
          "sentence_id": "1",
          "sentence": "然而根据循证医学证据，手术对于肥胖及相关代谢综合征的治疗效果，年龄并不是一个显著的影响因素，且对于青少年而言，生理、心理发育程度与生物学年龄不一定相符。",
          "start_idx": 41,
          "end_idx": 117,
          "entities": [
            {
              "entity_id": "T43",
              "entity": "肥胖",
              "entity_type": "Disease",
              "start_idx": 15,
              "end_idx": 17,
              "entity_en": "obesity"
            },
            {
              "entity_id": "T44",
              "entity": "代谢综合征",
              "entity_type": "Disease",
              "start_idx": 20,
              "end_idx": 25,
              "entity_en": "Metabolic syndrome"
            }
          ],
          "relations": [],
          "sentence_en": "However, according to evidence-based medicine, age is not a significant factor affecting the effectiveness of surgery in treating obesity and related metabolic syndromes, and for adolescents, the degree of physiological and psychological development may not be consistent with their biological age."
        },
        {
          "sentence_id": "2",
          "sentence": "故我们认为对于年龄的建议可根据临床评估结果适当放宽，特别是对于青少年，在经过对肥胖程度及代谢性疾病严重程度的评估、患者及家庭成员心理评估、术后管理依从性评估之后可慎重考虑手术。",
          "start_idx": 117,
          "end_idx": 205,
          "entities": [
            {
              "entity_id": "T45",
              "entity": "肥胖",
              "entity_type": "Disease",
              "start_idx": 39,
              "end_idx": 41,
              "entity_en": "obesity"
            },
            {
              "entity_id": "T46",
              "entity": "代谢性疾病",
              "entity_type": "Disease",
              "start_idx": 44,
              "end_idx": 49,
              "entity_en": "Metabolic diseases"
            }
          ],
          "relations": [],
          "sentence_en": "Therefore, we believe that the age recommendation can be appropriately relaxed based on the results of clinical evaluation, especially for adolescents. Surgery can be carefully considered after evaluating the degree of obesity and severity of metabolic diseases, psychological evaluation of patients and family members, and evaluation of compliance with postoperative management."
        }
      ],
      "paragraph_en": "The \"Guidelines for the Surgical Treatment of Obesity and Type 2 Diabetes in China (2014)\" set the recommended age for surgery at 16 to 65 years old. However, according to evidence-based medicine, age is not a significant factor in the treatment of obesity and related metabolic syndromes, and for adolescents, the degree of physiological and psychological development may not be consistent with biological age. Therefore, we believe that the age recommendation can be appropriately relaxed based on clinical evaluation results, especially for adolescents, who can carefully consider surgery after evaluating the degree of obesity and the severity of metabolic diseases, psychological evaluation of patients and family members, and evaluation of postoperative management compliance."
    },
    {
      "paragraph_id": "7",
      "paragraph": "三、手术方式",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "三、手术方式",
          "start_idx": 0,
          "end_idx": 6,
          "entities": [],
          "relations": [],
          "sentence_en": "3. Surgical Method"
        }
      ],
      "paragraph_en": "3. Surgical Method"
    },
    {
      "paragraph_id": "8",
      "paragraph": "目前推荐的手术方式包括：(1)腹腔镜Roux-en-Y胃旁路术(laparoscopic Roux-en-Y gastric bypass，LRYGB)；(2)腹腔镜胃袖状切除术(laparoscopic sleeve gastrectomy，LSG)；(3)胆胰分流并十二指肠转位术(biliopancreatic diversion with duodenal switch，BPD-DS)，其中BPD-DS虽然效果最好，但其并发症发生率有所增加，术后常见维生素和微量元素的缺乏，术后随访和维生素微量元素补充要求严格且长期，故需慎重选择。",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "目前推荐的手术方式包括：(1)腹腔镜Roux-en-Y胃旁路术(laparoscopic Roux-en-Y gastric bypass，LRYGB)；(2)腹腔镜胃袖状切除术(laparoscopic sleeve gastrectomy，LSG)；(3)胆胰分流并十二指肠转位术(biliopancreatic diversion with duodenal switch，BPD-DS)，其中BPD-DS虽然效果最好，但其并发症发生率有所增加，术后常见维生素和微量元素的缺乏，术后随访和维生素微量元素补充要求严格且长期，故需慎重选择。",
          "start_idx": 0,
          "end_idx": 271,
          "entities": [
            {
              "entity_id": "T47",
              "entity": "腹腔镜Roux-en-Y胃旁路术(laparoscopic Roux-en-Y gastric bypass，LRYGB)",
              "entity_type": "Operation",
              "start_idx": 15,
              "end_idx": 76,
              "entity_en": "Laparoscopic Roux-en-Y gastric bypass (LRYGB)"
            },
            {
              "entity_id": "T48",
              "entity": "腹腔镜胃袖状切除术(laparoscopic sleeve gastrectomy，LSG)",
              "entity_type": "Operation",
              "start_idx": 80,
              "end_idx": 126,
              "entity_en": "Laparoscopic sleeve gastrectomy (LSG)"
            },
            {
              "entity_id": "T49",
              "entity": "胆胰分流并十二指肠转位术(biliopancreatic diversion with duodenal switch，BPD-DS)",
              "entity_type": "Operation",
              "start_idx": 130,
              "end_idx": 197,
              "entity_en": "Biliopancreatic diversion with duodenal switch (BPD-DS)"
            },
            {
              "entity_id": "T50",
              "entity": "BPD-DS",
              "entity_type": "Operation",
              "start_idx": 200,
              "end_idx": 206,
              "entity_en": "BPD-DS"
            },
            {
              "entity_id": "T51",
              "entity": "维生素和微量元素的缺乏",
              "entity_type": "ADE",
              "start_idx": 230,
              "end_idx": 241,
              "entity_en": "Deficiency of vitamins and trace elements"
            }
          ],
          "relations": [],
          "sentence_en": "Currently recommended surgical methods include: (1) laparoscopic Roux-en-Y gastric bypass (LRYGB); (2) laparoscopic sleeve gastrectomy (LSG); and (3) biliopancreatic diversion with duodenal switch (BPD-DS). Although BPD-DS has the best effect, its complication rate is increased. Vitamin and trace element deficiencies are common after surgery. Postoperative follow-up and vitamin and trace element supplementation require strict and long-term requirements, so it needs to be carefully selected."
        }
      ],
      "paragraph_en": "Currently recommended surgical methods include: (1) laparoscopic Roux-en-Y gastric bypass (LRYGB); (2) laparoscopic sleeve gastrectomy (LSG); and (3) biliopancreatic diversion with duodenal switch (BPD-DS). Although BPD-DS has the best effect, its complication rate is increased. Vitamin and trace element deficiencies are common after surgery. Postoperative follow-up and vitamin and trace element supplementation require strict and long-term requirements, so it needs to be carefully selected."
    },
    {
      "paragraph_id": "9",
      "paragraph": "另外，目前国内外报道多种新术式，包括在胃旁路术基础上发展的mini-bypass、袖状胃切除术基础上发展的“SG+X术”、以及胃折叠术、空回肠侧侧吻合术等，这些指南推荐之外的术式均尚缺乏中长期疗效数据，不建议临床推广，仅限于临床研究。",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "另外，目前国内外报道多种新术式，包括在胃旁路术基础上发展的mini-bypass、袖状胃切除术基础上发展的“SG+X术”、以及胃折叠术、空回肠侧侧吻合术等，这些指南推荐之外的术式均尚缺乏中长期疗效数据，不建议临床推广，仅限于临床研究。",
          "start_idx": 0,
          "end_idx": 117,
          "entities": [
            {
              "entity_id": "T52",
              "entity": "胃旁路术",
              "entity_type": "Operation",
              "start_idx": 19,
              "end_idx": 23,
              "entity_en": "Gastric bypass surgery"
            },
            {
              "entity_id": "T53",
              "entity": "mini-bypass",
              "entity_type": "Operation",
              "start_idx": 29,
              "end_idx": 40,
              "entity_en": "mini-bypass"
            },
            {
              "entity_id": "T54",
              "entity": "袖状胃切除术",
              "entity_type": "Operation",
              "start_idx": 41,
              "end_idx": 47,
              "entity_en": "Sleeve gastrectomy"
            },
            {
              "entity_id": "T55",
              "entity": "SG+X术",
              "entity_type": "Operation",
              "start_idx": 54,
              "end_idx": 59,
              "entity_en": "SG+X"
            },
            {
              "entity_id": "T56",
              "entity": "胃折叠术",
              "entity_type": "Operation",
              "start_idx": 63,
              "end_idx": 67,
              "entity_en": "Gastric plication"
            },
            {
              "entity_id": "T57",
              "entity": "空回肠侧侧吻合术",
              "entity_type": "Operation",
              "start_idx": 68,
              "end_idx": 76,
              "entity_en": "Side-to-side jejunoileal anastomosis"
            }
          ],
          "relations": [],
          "sentence_en": "In addition, many new surgical procedures have been reported both at home and abroad, including mini-bypass developed based on gastric bypass, \"SG+X\" developed based on sleeve gastrectomy, as well as gastric plication and jejunoileal side-to-side anastomosis. These surgical procedures outside the guidelines lack medium- and long-term efficacy data and are not recommended for clinical promotion and are limited to clinical research."
        }
      ],
      "paragraph_en": "In addition, many new surgical procedures have been reported both at home and abroad, including mini-bypass developed based on gastric bypass, \"SG+X\" developed based on sleeve gastrectomy, as well as gastric plication and jejunoileal side-to-side anastomosis. These surgical procedures outside the guidelines lack medium- and long-term efficacy data and are not recommended for clinical promotion and are limited to clinical research."
    },
    {
      "paragraph_id": "10",
      "paragraph": "四、术后随访",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "四、术后随访",
          "start_idx": 0,
          "end_idx": 6,
          "entities": [],
          "relations": [],
          "sentence_en": "IV. Postoperative Follow-up"
        }
      ],
      "paragraph_en": "IV. Postoperative Follow-up"
    },
    {
      "paragraph_id": "11",
      "paragraph": "接受肥胖与糖尿病外科手术患者均需终身随访，临床实践中不少医疗机构对接受减重代谢手术的病人缺少规律的随访，致使手术的安全性和有效性缺乏保障。指南确定术后1年内应至少进行4次随访，建议门诊随访，另需更多次的电话或其他方式随访，术后1个月起应对糖尿病改善进行较为完善的评估，包括血糖、糖化血红蛋白、胰岛素、C肽等，术后6个月起应对血生化、营养状况及心理、精神评估进行完善，内容应包括骨密度、维生素及微量元素水平，同时监测是否有手术并发症，进行必要的干预。",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "接受肥胖与糖尿病外科手术患者均需终身随访，临床实践中不少医疗机构对接受减重代谢手术的病人缺少规律的随访，致使手术的安全性和有效性缺乏保障。指南确定术后1年内应至少进行4次随访，建议门诊随访，另需更多次的电话或其他方式随访，术后1个月起应对糖尿病改善进行较为完善的评估，包括血糖、糖化血红蛋白、胰岛素、C肽等，术后6个月起应对血生化、营养状况及心理、精神评估进行完善，内容应包括骨密度、维生素及微量元素水平，同时监测是否有手术并发症，进行必要的干预。",
          "start_idx": 0,
          "end_idx": 224,
          "entities": [
            {
              "entity_id": "T58",
              "entity": "肥胖",
              "entity_type": "Disease",
              "start_idx": 2,
              "end_idx": 4,
              "entity_en": "obesity"
            },
            {
              "entity_id": "T59",
              "entity": "糖尿病",
              "entity_type": "Disease",
              "start_idx": 5,
              "end_idx": 8,
              "entity_en": "diabetes"
            },
            {
              "entity_id": "T60",
              "entity": "减重代谢手术",
              "entity_type": "Operation",
              "start_idx": 35,
              "end_idx": 41,
              "entity_en": "Bariatric metabolic surgery"
            },
            {
              "entity_id": "T61",
              "entity": "血糖",
              "entity_type": "Test_items",
              "start_idx": 136,
              "end_idx": 138,
              "entity_en": "blood sugar"
            },
            {
              "entity_id": "T62",
              "entity": "糖化血红蛋白",
              "entity_type": "Test_items",
              "start_idx": 139,
              "end_idx": 145,
              "entity_en": "Glycated hemoglobin"
            },
            {
              "entity_id": "T63",
              "entity": "胰岛素",
              "entity_type": "Test_items",
              "start_idx": 146,
              "end_idx": 149,
              "entity_en": "insulin"
            },
            {
              "entity_id": "T64",
              "entity": "C肽",
              "entity_type": "Test_items",
              "start_idx": 150,
              "end_idx": 152,
              "entity_en": "C-Peptide"
            },
            {
              "entity_id": "T65",
              "entity": "血生化",
              "entity_type": "Test",
              "start_idx": 162,
              "end_idx": 165,
              "entity_en": "Blood biochemistry"
            },
            {
              "entity_id": "T66",
              "entity": "骨密度",
              "entity_type": "Test",
              "start_idx": 188,
              "end_idx": 191,
              "entity_en": "Bone density"
            },
            {
              "entity_id": "T67",
              "entity": "维生素",
              "entity_type": "Test",
              "start_idx": 192,
              "end_idx": 195,
              "entity_en": "Vitamins"
            },
            {
              "entity_id": "T68",
              "entity": "微量元素水平",
              "entity_type": "Test",
              "start_idx": 196,
              "end_idx": 202,
              "entity_en": "Trace element levels"
            },
            {
              "entity_id": "T69",
              "entity": "糖尿病",
              "entity_type": "Disease",
              "start_idx": 119,
              "end_idx": 122,
              "entity_en": "diabetes"
            }
          ],
          "relations": [
            {
              "relation_type": "Operation_Disease",
              "relation_id": "R8",
              "head_entity_id": "T60",
              "tail_entity_id": "T58"
            },
            {
              "relation_type": "Operation_Disease",
              "relation_id": "R9",
              "head_entity_id": "T60",
              "tail_entity_id": "T59"
            },
            {
              "relation_type": "Test_items_Disease",
              "relation_id": "R10",
              "head_entity_id": "T61",
              "tail_entity_id": "T69"
            },
            {
              "relation_type": "Test_items_Disease",
              "relation_id": "R11",
              "head_entity_id": "T62",
              "tail_entity_id": "T69"
            },
            {
              "relation_type": "Test_items_Disease",
              "relation_id": "R12",
              "head_entity_id": "T63",
              "tail_entity_id": "T69"
            },
            {
              "relation_type": "Test_items_Disease",
              "relation_id": "R13",
              "head_entity_id": "T64",
              "tail_entity_id": "T69"
            }
          ],
          "sentence_en": "Patients who undergo surgical surgery for obesity and diabetes need lifelong follow-up. In clinical practice, many medical institutions lack regular follow-up for patients who undergo weight loss and metabolic surgery, resulting in a lack of guarantee for the safety and effectiveness of the surgery. The guidelines stipulate that at least four follow-ups should be conducted within one year after surgery. Outpatient follow-up is recommended, and more follow-ups by phone or other means are required. A more comprehensive assessment of diabetes improvement should be conducted one month after surgery, including blood sugar, glycosylated hemoglobin, insulin, C-peptide, etc. From six months after surgery, blood biochemistry, nutritional status, and psychological and mental assessments should be improved, including bone density, vitamin and trace element levels, and at the same time, monitoring for surgical complications and necessary interventions should be carried out."
        }
      ],
      "paragraph_en": "Patients who undergo surgical surgery for obesity and diabetes need lifelong follow-up. In clinical practice, many medical institutions lack regular follow-up for patients who undergo weight loss and metabolic surgery, resulting in a lack of guarantee for the safety and effectiveness of the surgery. The guidelines stipulate that at least four follow-ups should be conducted within one year after surgery. Outpatient follow-up is recommended, and more follow-ups by phone or other means are required. A more comprehensive assessment of diabetes improvement should be conducted one month after surgery, including blood sugar, glycosylated hemoglobin, insulin, C-peptide, etc. From six months after surgery, blood biochemistry, nutritional status, and psychological and mental assessments should be improved, including bone density, vitamin and trace element levels, and at the same time, monitoring for surgical complications and necessary interventions should be carried out."
    },
    {
      "paragraph_id": "12",
      "paragraph": "五、总结",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "五、总结",
          "start_idx": 0,
          "end_idx": 4,
          "entities": [],
          "relations": [],
          "sentence_en": "V. Conclusion"
        }
      ],
      "paragraph_en": "V. Conclusion"
    },
    {
      "paragraph_id": "13",
      "paragraph": "综上所述，肥胖与糖尿病外科手术的开展必须遵循指南，以确保医疗质量和安全，各地医师协会对肥胖与糖尿病外科的发展应起到监管作用，规范肥胖与糖尿病外科手术的管理。",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "综上所述，肥胖与糖尿病外科手术的开展必须遵循指南，以确保医疗质量和安全，各地医师协会对肥胖与糖尿病外科的发展应起到监管作用，规范肥胖与糖尿病外科手术的管理。",
          "start_idx": 0,
          "end_idx": 78,
          "entities": [
            {
              "entity_id": "T70",
              "entity": "肥胖",
              "entity_type": "Disease",
              "start_idx": 5,
              "end_idx": 7,
              "entity_en": "obesity"
            },
            {
              "entity_id": "T71",
              "entity": "糖尿病",
              "entity_type": "Disease",
              "start_idx": 8,
              "end_idx": 11,
              "entity_en": "diabetes"
            },
            {
              "entity_id": "T72",
              "entity": "肥胖",
              "entity_type": "Disease",
              "start_idx": 43,
              "end_idx": 45,
              "entity_en": "obesity"
            },
            {
              "entity_id": "T73",
              "entity": "糖尿病",
              "entity_type": "Disease",
              "start_idx": 46,
              "end_idx": 49,
              "entity_en": "diabetes"
            },
            {
              "entity_id": "T74",
              "entity": "肥胖",
              "entity_type": "Disease",
              "start_idx": 64,
              "end_idx": 66,
              "entity_en": "obesity"
            },
            {
              "entity_id": "T75",
              "entity": "糖尿病",
              "entity_type": "Disease",
              "start_idx": 67,
              "end_idx": 70,
              "entity_en": "diabetes"
            }
          ],
          "relations": [],
          "sentence_en": "In summary, the implementation of obesity and diabetes surgery must follow guidelines to ensure medical quality and safety. Local medical associations should play a supervisory role in the development of obesity and diabetes surgery and standardize the management of obesity and diabetes surgery."
        }
      ],
      "paragraph_en": "In summary, the implementation of obesity and diabetes surgery must follow guidelines to ensure medical quality and safety. Local medical associations should play a supervisory role in the development of obesity and diabetes surgery and standardize the management of obesity and diabetes surgery."
    }
  ]
}